CLINICAL_TRIALS
research
· 2017-03-14
Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children [NA]
Summary
This document reports a clinical trial evaluating the efficacy and safety of CAR-T therapy in children with relapsed or refractory neuroblastoma. Status of the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sinobioway Cell Therapy Co., Ltd. | Conditions: Relapsed or Refractory Neuroblastoma | NA | Status: UNKNOWN